XML 14 R5.htm IDEA: XBRL DOCUMENT v3.23.3
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Common Stock.
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Total
Balance at Dec. 31, 2021 $ 5 $ 361,669 $ 1,869 $ (266,381) $ 97,162
Balance (in shares) at Dec. 31, 2021 46,553,511        
Stock-based compensation expense   739     739
Unrealized gain (loss) on marketable securities     (28)   (28)
Foreign currency translation adjustment     146   146
Net loss       (8,297) (8,297)
Balance at Mar. 31, 2022 $ 5 362,408 1,987 (274,678) 89,722
Balance (in shares) at Mar. 31, 2022 46,553,511        
Balance at Dec. 31, 2021 $ 5 361,669 1,869 (266,381) 97,162
Balance (in shares) at Dec. 31, 2021 46,553,511        
Foreign currency translation adjustment         (2,985)
Net loss         (31,491)
Balance at Sep. 30, 2022 $ 5 363,741 (1,193) (297,872) 64,681
Balance (in shares) at Sep. 30, 2022 46,553,511        
Balance at Mar. 31, 2022 $ 5 362,408 1,987 (274,678) 89,722
Balance (in shares) at Mar. 31, 2022 46,553,511        
Stock-based compensation expense   675     675
Unrealized gain (loss) on marketable securities     (54)   (54)
Foreign currency translation adjustment     (1,594)   (1,594)
Net loss       (8,363) (8,363)
Balance at Jun. 30, 2022 $ 5 363,083 339 (283,041) 80,386
Balance (in shares) at Jun. 30, 2022 46,553,511        
Stock-based compensation expense   658     658
Unrealized gain (loss) on marketable securities     5   5
Foreign currency translation adjustment     (1,537)   (1,537)
Net loss       (14,831) (14,831)
Balance at Sep. 30, 2022 $ 5 363,741 (1,193) (297,872) 64,681
Balance (in shares) at Sep. 30, 2022 46,553,511        
Balance at Dec. 31, 2022 $ 5 364,361 (563) (307,688) 56,115
Balance (in shares) at Dec. 31, 2022 46,553,511        
Common stock issued on exercise of stock options   4     4
Common stock issued on exercise of stock options (in shares) 15,000        
Stock-based compensation expense   492     492
Unrealized gain (loss) on marketable securities     41   41
Foreign currency translation adjustment     88   88
Net loss       (7,873) (7,873)
Balance at Mar. 31, 2023 $ 5 364,857 (434) (315,561) 48,867
Balance (in shares) at Mar. 31, 2023 46,568,511        
Balance at Dec. 31, 2022 $ 5 364,361 (563) (307,688) 56,115
Balance (in shares) at Dec. 31, 2022 46,553,511        
Foreign currency translation adjustment         (925)
Net loss         (20,376)
Balance at Sep. 30, 2023 $ 5 373,791 (1,443) (328,064) 44,289
Balance (in shares) at Sep. 30, 2023 49,038,582        
Balance at Mar. 31, 2023 $ 5 364,857 (434) (315,561) 48,867
Balance (in shares) at Mar. 31, 2023 46,568,511        
Issuance of common stock in connection with at-the-market offering, net   7,516     7,516
Issuance of common stock in connection with at-the-market offering, net (Shares) 2,329,851        
Stock-based compensation expense   537     537
Unrealized gain (loss) on marketable securities     (1)   (1)
Foreign currency translation adjustment     (933)   (933)
Net loss       (6,503) (6,503)
Balance at Jun. 30, 2023 $ 5 372,910 (1,368) (322,064) 49,483
Balance (in shares) at Jun. 30, 2023 48,898,362        
Issuance of common stock in connection with at-the-market offering, net   327     327
Issuance of common stock in connection with at-the-market offering, net (Shares) 132,052        
Common stock issued on exercise of stock options   8     8
Common stock issued on exercise of stock options (in shares) 8,168        
Stock-based compensation expense   546     546
Unrealized gain (loss) on marketable securities     5   5
Foreign currency translation adjustment     (80)   (80)
Net loss       (6,000) (6,000)
Balance at Sep. 30, 2023 $ 5 $ 373,791 $ (1,443) $ (328,064) $ 44,289
Balance (in shares) at Sep. 30, 2023 49,038,582